CIDRAP newsletters options
People with positive home test results had significantly lower odds of isolating for any length of time than those with provider results.
Sequential vaccines, like those used for COVID-19, may elicit a greater immune response if the recipient has the same arm injected.
A woman and her husband and daughter have all been infected, likely with bubonic plague.
Virologists report what appears to be a second-generation BA.2 lineage Omicron virus with many spike protein mutations.
Patients who were older than 75 or reported good drug adherence benefited the most from the drugs.
The only statistically significant difference at 1 year between the two groups was with extreme fatigue (3.5% of COVID-positive vs 6.8% -negative).
Teleworking during COVID-19 generally had a positive impact on worker productivity and corporate bottom lines in some sectors.
Pooling of blood in the legs that causes them to turn blue may be yet another symptom of long COVID.
For the first time, Argentina confirms H5 avian flu in mammals; also, Russia reports H5N1 at a large poultry farm.
Patients with COVID-19 also saw a sixfold higher rate of in-hospital deaths.
Reported COVID deaths ticked upward for the first time in several weeks, though levels are still very low.
The CDC's Fernanda Lessa talks about high levels of antimicrobial resistance in poorer nations and what the CDC is doing to help limit its spread.
A literature review finds that athletes engaged in intensive activity are not at increased risk for heart complications following vaccination.
Bangladesh is experiencing an unusual surge in activity that started earlier than usual and has a relatively high case-fatality rate.
Pakistan has its second wild poliovirus type 1 case of the year, 4 countries report rising mpox, and the WHO has new resources.
Long-COVID prevalence started declining last June, but the drop has stalled since January.
Researchers estimate that more than 2 of every 5 deaths that involved an infection in the Region of the Americas in 2019 were associated with antibiotic resistance.
Remdesivir is an important option for patients who lack the COVID-19 treatment options available to non-immunocompromised patients.
Implementing recommended infection control measures and ensuring patients and staff members are up to date with COVID-19 vaccination are critical in dialysis settings, the authors said.
The authors say the reasons for this difference are likely multifactorial, though difference in educational emphasis on antibiotic stewardship may play a role.
